Psilocybin and its active metabolite psilocin are well known components of magic mushrooms (Figure 1). Due to exciting results highlighting the potential of using these compounds as mental health treatments, they have emerged as a topic of significant scientific interest. But, until recently, very little attention had been paid to other close structural analogs of these compounds…

Source

Previous articlePα+ Psychedelic Bulletin #158: Fluence Brings Psychedelic Therapy Training to Ukraine; MindBio’s Microdosing Readout; Biomind’s 5-MeO-DMT Study; and more…
Next articleFDA Hands MindMed’s LSD Candidate Breakthrough Therapy Designation in Generalised Anxiety Disorder; Company Provides 12-Week Data and Fleshes Out Phase 3 Program Plans